Microlife Aponorm Professional Control, Инструкция по эксплуатации

Страница: 5 / 22

5
Dear Customer,
This monitor was developed in collaboration with
physicians and clinical tests prove its measure-
ment accuracy to be very high.*
Microlife AFIBsens is the world’s leading digital
blood pressure measuring technology for detecting
atrial fibrillation (A-fib) and arterial hypertension.
These are the two best known risk factors for
a stroke or future heart diseases. It is essential
that atrial fibrillation and high blood pressure are
detected at an early stage, even if the patient
does not feel any symptoms yet. An examination
for atrial fibrillation is recommended from the age
of 65 onwards, generally and with the Microlife
AFIB algorithm. The AFIB algorithm shows that
the patient possibly suffers from atrial fibrillation.
Therefore, we recommend you to see your doctor if
the AFIB symbol is displayed on a regular basis.
The Microlife AFIB algorithm was developed and
clinically tested in cooperation with internationally
renowned medical specialists. Atrial fibrillation is
detected with a certainty of 97 to 100%.
1,2
If you have any questions or problems or want to
order spare parts, please contact the aponorm
®
customer service at the product website www.
aponorm.de or the distributor where you purchased
the monitor. The product website provides much
additional useful information on your product.
Stay healthy - the aponorm
®
team!
* This device uses the same measuring technology as the award
winning «BP 3BTO-A» model tested according to the British and
Irish Hypertension Society (BIHS) protocol.
1 Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D,
Hobbs FR et al.: Triage tests for identifying atrial fibrillation in
primary care: a diagnostic accuracy study comparing single-lead
ECG and modified BP monitors. BMJ Open 2014; 4:e004565.
2 Wiesel J, Arbesfeld B, Schechter D: Comparison of the Microli-
fe blood pressure monitor with the Omron blood pressure monitor
for detecting atrial fibrillation. Am J Cardiol 2014; 114:1046-1048.